Efficacy and safety of phacoemulsification and trifocal intraocular lens

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20161110003

Enrollment

Registered

2016-11-10

Start date

2015-11-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

Cataract surgery was done with Trifocol IOL implantation in both eyes

Experimental Device

Trifocal intraocular lens

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients with visual threatening cataract in both eyes and age > 18 year old

Exclusion criteria

Exclusion criteria: patients with complicated cataract patients with other eye diseases with may impaired visual outcome patients with systemic diseases with may impaired visual outcome patients with inappropriate to implant trifocal IOL in both eyes

Design outcomes

Primary

Measure	Time frame
Best-corrected visual acuity post-op day1, 1 week, 1,3,6 months Snellen chart	—

Secondary

Measure	Time frame
optical aberration post-op 1 week, 1,3,6 months aberrometer,intermeadiate and near visual acuity post-op day1, 1 week, 1,3,6 months intermeadiate and near chart	—

Countries

Thailand

Contacts

Public ContactUsanee Reinprayoon

King Chulalongkorn Memorial Hospital

usaneer@gmail.com022564421

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026